Free Trial
ASX:MSB

Mesoblast (MSB) Stock Price, News & Analysis

Mesoblast logo

About Mesoblast Stock (ASX:MSB)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
10.19 million shs
Average Volume
N/A
Market Capitalization
A$2.32 billion
P/E Ratio
N/A
Dividend Yield
2.58%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MSB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mesoblast and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MSB Stock News Headlines

Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.tc pixel
Mesoblast Limited: Successful Commercial Launch of Ryoncil
See More Headlines

MSB Stock Analysis - Frequently Asked Questions

Mesoblast Limited (ASX:MSB) issued its earnings results on Thursday, February, 21st. The company reported ($0.09) earnings per share (EPS) for the quarter. Mesoblast had a negative trailing twelve-month return on equity of 17.79% and a negative net margin of 1,490.27%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Mesoblast investors own include Mesoblast (MESO), Fortescue (FMG), Strategy (MSTR), Aus Tin Mining (ANW), OceanaGold (OGC), Piedmont Lithium (PLL) and Alliance Resource Partners (ARLP).

Company Calendar

Last Earnings
2/21/2019
Today
8/27/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
Trading
Current Symbol
ASX:MSB
CIK
N/A
Fax
N/A
Employees
83
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A($0.13)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
9.56
Net Income
-A$87.96 million
Net Margins
-1,490.27%
Pretax Margin
N/A
Return on Equity
-17.79%
Return on Assets
-5.41%

Debt

Debt-to-Equity Ratio
24.76
Current Ratio
1.18
Quick Ratio
1.82

Sales & Book Value

Annual Sales
A$5.90 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
30.00
Book Value
A$0.43 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
1,140,000,000
Free Float
N/A
Market Cap
A$2.32 billion
Optionable
Not Optionable
Beta
2.38
10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (ASX:MSB) was last updated on 8/27/2025 by MarketBeat.com Staff
From Our Partners